Medivo, a US-based online health monitoring platform, has raised $15m in series B financing led by the Global Health Innovation Fund (GHIF) of US-based healthcare company Merck, with participation from existing investors, company builder Safeguard Scientifics and early-stage venture capital fund MentorTech Ventures. To date, Medivo has raised over $22m to support its analytics capabilities and health…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
